| 0 |
MECHANICAL VENTILATION COMPLICATION |
25 |
0.1678 |
| 1 |
POST PROCEDURAL HYPOTENSION |
11 |
0.1294 |
| 2 |
INSPIRATORY CAPACITY DECREASED |
26 |
0.0939 |
| 3 |
PUNCTURE SITE HAEMATOMA |
6 |
0.0938 |
| 4 |
FACTOR VII DEFICIENCY |
6 |
0.0896 |
| 5 |
RENAL CORTICAL NECROSIS |
17 |
0.0730 |
| 6 |
MESENTERIC VASCULAR INSUFFICIENCY |
7 |
0.0636 |
| 7 |
OVARIAN VEIN THROMBOSIS |
8 |
0.0530 |
| 8 |
RED BLOOD CELL TRANSFUSION |
16 |
0.0390 |
| 9 |
HAEMOPHILIA |
8 |
0.0374 |
| 10 |
FALLOPIAN TUBE DISORDER |
11 |
0.0373 |
| 11 |
TRI-IODOTHYRONINE FREE DECREASED |
9 |
0.0353 |
| 12 |
ADNEXAL TORSION |
11 |
0.0347 |
| 13 |
ELECTROCARDIOGRAM PR SHORTENED |
7 |
0.0333 |
| 14 |
CONGENITAL ORAL MALFORMATION |
7 |
0.0320 |
| 15 |
PARENTERAL NUTRITION |
7 |
0.0303 |
| 16 |
MATERNAL EXPOSURE DURING DELIVERY |
30 |
0.0303 |
| 17 |
BILIARY SEPSIS |
14 |
0.0302 |
| 18 |
DISABILITY ASSESSMENT SCALE SCORE INCREASED |
9 |
0.0293 |
| 19 |
HAEMOPHILIC ARTHROPATHY |
7 |
0.0293 |
| 20 |
FIBRIN DEGRADATION PRODUCTS INCREASED |
8 |
0.0270 |
| 21 |
ENTEROCOCCAL SEPSIS |
21 |
0.0259 |
| 22 |
CEREBRAL VENOUS SINUS THROMBOSIS |
21 |
0.0249 |
| 23 |
DREAMY STATE |
7 |
0.0216 |
| 24 |
ACUTE LEFT VENTRICULAR FAILURE |
14 |
0.0208 |
| 25 |
APLASTIC ANAEMIA |
105 |
0.0201 |
| 26 |
JOINT ANKYLOSIS |
11 |
0.0194 |
| 27 |
INFUSION SITE SCAR |
8 |
0.0181 |
| 28 |
MYOCLONIC EPILEPSY |
27 |
0.0178 |
| 29 |
HAEMOTHORAX |
51 |
0.0176 |
| 30 |
FACTOR VIII INHIBITION |
18 |
0.0171 |
| 31 |
HER2 POSITIVE BREAST CANCER |
6 |
0.0160 |
| 32 |
PLATELET TRANSFUSION |
20 |
0.0155 |
| 33 |
BASOPHIL COUNT INCREASED |
10 |
0.0132 |
| 34 |
WRONG PRODUCT ADMINISTERED |
88 |
0.0130 |
| 35 |
VASODILATATION |
32 |
0.0127 |
| 36 |
PERFORATION |
10 |
0.0124 |
| 37 |
FIBROMA |
11 |
0.0120 |
| 38 |
CORONARY ARTERY THROMBOSIS |
24 |
0.0119 |
| 39 |
POSTPARTUM HAEMORRHAGE |
16 |
0.0119 |
| 40 |
CEREBRAL ARTERY THROMBOSIS |
6 |
0.0117 |
| 41 |
BRONCHIAL HYPERREACTIVITY |
14 |
0.0116 |
| 42 |
HEREDITARY ANGIOEDEMA |
124 |
0.0115 |
| 43 |
URINE LEUKOCYTE ESTERASE POSITIVE |
8 |
0.0114 |
| 44 |
LOCAL ANAESTHETIC SYSTEMIC TOXICITY |
12 |
0.0113 |
| 45 |
MYOCLONUS |
133 |
0.0111 |
| 46 |
NEUROGENIC SHOCK |
6 |
0.0111 |
| 47 |
HAEMORRHAGIC DISORDER |
12 |
0.0110 |
| 48 |
STRIDOR |
32 |
0.0109 |
| 49 |
PRODUCT APPEARANCE CONFUSION |
10 |
0.0108 |
| 50 |
NEONATAL RESPIRATORY DISTRESS |
10 |
0.0106 |
| 51 |
PRODUCT PACKAGING CONFUSION |
25 |
0.0103 |
| 52 |
HYPORESPONSIVE TO STIMULI |
12 |
0.0102 |
| 53 |
PLASMA CELL LEUKAEMIA |
6 |
0.0100 |
| 54 |
PUNCTURE SITE HAEMORRHAGE |
7 |
0.0099 |
| 55 |
UTERINE DISORDER |
23 |
0.0099 |
| 56 |
VASCULAR STENT THROMBOSIS |
20 |
0.0098 |
| 57 |
DYSCHROMATOPSIA |
8 |
0.0097 |
| 58 |
ARTERIAL HAEMORRHAGE |
11 |
0.0096 |
| 59 |
IMMUNE THROMBOCYTOPENIA |
43 |
0.0094 |
| 60 |
ABSCESS ORAL |
12 |
0.0087 |
| 61 |
INFUSION SITE DISCOMFORT |
9 |
0.0087 |
| 62 |
STATUS EPILEPTICUS |
95 |
0.0084 |
| 63 |
RETINAL ARTERY OCCLUSION |
21 |
0.0083 |
| 64 |
PCO2 DECREASED |
8 |
0.0083 |
| 65 |
SHOCK HAEMORRHAGIC |
67 |
0.0082 |
| 66 |
SPONTANEOUS HAEMORRHAGE |
8 |
0.0078 |
| 67 |
GASTROINTESTINAL VIRAL INFECTION |
8 |
0.0077 |
| 68 |
NAIL INFECTION |
11 |
0.0077 |
| 69 |
JOINT NOISE |
15 |
0.0076 |
| 70 |
BLOOD FIBRINOGEN INCREASED |
6 |
0.0076 |
| 71 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
10 |
0.0076 |
| 72 |
SYSTOLIC DYSFUNCTION |
8 |
0.0076 |
| 73 |
UPPER RESPIRATORY TRACT INFLAMMATION |
9 |
0.0075 |
| 74 |
HAEMOPERITONEUM |
6 |
0.0075 |
| 75 |
INFERTILITY |
11 |
0.0073 |
| 76 |
SLEEP DEFICIT |
15 |
0.0071 |
| 77 |
LOWER RESPIRATORY TRACT CONGESTION |
12 |
0.0071 |
| 78 |
URINE KETONE BODY PRESENT |
11 |
0.0070 |
| 79 |
GENERALISED TONIC-CLONIC SEIZURE |
113 |
0.0068 |
| 80 |
NOSOCOMIAL INFECTION |
15 |
0.0068 |
| 81 |
OESOPHAGEAL HAEMORRHAGE |
9 |
0.0068 |
| 82 |
LABILE BLOOD PRESSURE |
8 |
0.0067 |
| 83 |
INFUSION SITE WARMTH |
8 |
0.0065 |
| 84 |
COAGULATION TIME PROLONGED |
10 |
0.0065 |
| 85 |
BRAIN STEM HAEMORRHAGE |
6 |
0.0063 |
| 86 |
UTERINE HAEMORRHAGE |
27 |
0.0063 |
| 87 |
HEAVY MENSTRUAL BLEEDING |
56 |
0.0062 |
| 88 |
BLOOD FIBRINOGEN DECREASED |
7 |
0.0061 |
| 89 |
ISCHAEMIC CEREBRAL INFARCTION |
7 |
0.0060 |
| 90 |
PROCALCITONIN INCREASED |
7 |
0.0060 |
| 91 |
EMBOLISM VENOUS |
18 |
0.0059 |
| 92 |
NEUTROPENIC SEPSIS |
42 |
0.0059 |
| 93 |
VENOOCCLUSIVE LIVER DISEASE |
29 |
0.0059 |
| 94 |
CANCER PAIN |
15 |
0.0059 |
| 95 |
INFUSION SITE RASH |
8 |
0.0058 |
| 96 |
HYPOVOLAEMIA |
34 |
0.0058 |
| 97 |
MUSCLE HAEMORRHAGE |
22 |
0.0055 |
| 98 |
HAEMOGLOBIN INCREASED |
25 |
0.0055 |
| 99 |
TONIC CLONIC MOVEMENTS |
7 |
0.0054 |
| 100 |
PULMONARY HAEMORRHAGE |
42 |
0.0054 |
| 101 |
JAUNDICE NEONATAL |
10 |
0.0053 |
| 102 |
ADMINISTRATION SITE PAIN |
6 |
0.0052 |
| 103 |
OLIGOMENORRHOEA |
11 |
0.0050 |
| 104 |
PULSELESS ELECTRICAL ACTIVITY |
21 |
0.0050 |
| 105 |
ANGIOPATHY |
28 |
0.0050 |
| 106 |
PERIPHERAL ARTERY THROMBOSIS |
7 |
0.0050 |
| 107 |
PLATELET COUNT ABNORMAL |
30 |
0.0050 |
| 108 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
85 |
0.0050 |
| 109 |
PHARYNGEAL HAEMORRHAGE |
6 |
0.0049 |
| 110 |
HAEMODYNAMIC INSTABILITY |
37 |
0.0049 |
| 111 |
VENA CAVA THROMBOSIS |
8 |
0.0048 |
| 112 |
HAEMARTHROSIS |
43 |
0.0048 |
| 113 |
CLONUS |
13 |
0.0047 |
| 114 |
BLOOD PRESSURE DIASTOLIC ABNORMAL |
12 |
0.0047 |
| 115 |
TENOSYNOVITIS |
13 |
0.0047 |
| 116 |
GASTROINTESTINAL WALL THICKENING |
7 |
0.0047 |
| 117 |
HAEMORRHAGIC TRANSFORMATION STROKE |
7 |
0.0046 |
| 118 |
PURPURA |
41 |
0.0046 |
| 119 |
ISCHAEMIA |
21 |
0.0046 |
| 120 |
TUMOUR HAEMORRHAGE |
13 |
0.0046 |
| 121 |
HAEMORRHAGIC DIATHESIS |
16 |
0.0045 |
| 122 |
CYSTITIS HAEMORRHAGIC |
18 |
0.0045 |
| 123 |
BLOOD LOSS ANAEMIA |
10 |
0.0044 |
| 124 |
ATRIAL THROMBOSIS |
9 |
0.0043 |
| 125 |
DISINHIBITION |
7 |
0.0043 |
| 126 |
PROCEDURAL HAEMORRHAGE |
17 |
0.0043 |
| 127 |
TRANSFUSION |
45 |
0.0043 |
| 128 |
PROTHROMBIN TIME SHORTENED |
6 |
0.0043 |
| 129 |
ANAPHYLACTIC REACTION |
235 |
0.0042 |
| 130 |
TRAUMATIC HAEMORRHAGE |
8 |
0.0042 |
| 131 |
INTENSIVE CARE |
6 |
0.0042 |
| 132 |
URINARY TRACT OBSTRUCTION |
10 |
0.0042 |
| 133 |
MUCOSAL INFLAMMATION |
110 |
0.0042 |
| 134 |
POOR VENOUS ACCESS |
43 |
0.0042 |
| 135 |
FINE MOTOR SKILL DYSFUNCTION |
12 |
0.0041 |
| 136 |
ARTERIAL THROMBOSIS |
8 |
0.0041 |
| 137 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
11 |
0.0041 |
| 138 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
12 |
0.0041 |
| 139 |
PULMONARY ALVEOLAR HAEMORRHAGE |
23 |
0.0041 |
| 140 |
ELECTROCARDIOGRAM ST SEGMENT DEPRESSION |
9 |
0.0041 |
| 141 |
BACTERIAL TEST POSITIVE |
9 |
0.0040 |
| 142 |
FEBRILE NEUTROPENIA |
267 |
0.0040 |
| 143 |
ANAPHYLACTIC SHOCK |
103 |
0.0040 |
| 144 |
RHEUMATOID NODULE |
11 |
0.0040 |
| 145 |
HYPOVENTILATION |
13 |
0.0040 |
| 146 |
PLEURITIC PAIN |
11 |
0.0040 |
| 147 |
PLATELET DISORDER |
10 |
0.0040 |
| 148 |
IMMUNE THROMBOCYTOPENIC PURPURA |
11 |
0.0039 |
| 149 |
POST PROCEDURAL HAEMORRHAGE |
45 |
0.0039 |
| 150 |
PLATELET COUNT INCREASED |
50 |
0.0038 |
| 151 |
HYPERTRICHOSIS |
7 |
0.0038 |
| 152 |
COAGULOPATHY |
62 |
0.0037 |
| 153 |
LANGUAGE DISORDER |
8 |
0.0037 |
| 154 |
PERIORBITAL OEDEMA |
19 |
0.0037 |
| 155 |
INTRAVENTRICULAR HAEMORRHAGE |
9 |
0.0036 |
| 156 |
UTERINE LEIOMYOMA |
26 |
0.0036 |
| 157 |
CEREBELLAR INFARCTION |
6 |
0.0035 |
| 158 |
PNEUMONIA FUNGAL |
14 |
0.0035 |
| 159 |
OXYGEN SATURATION ABNORMAL |
10 |
0.0035 |
| 160 |
ALLERGIC REACTION TO EXCIPIENT |
7 |
0.0035 |
| 161 |
ABNORMAL UTERINE BLEEDING |
9 |
0.0035 |
| 162 |
BLOOD CHLORIDE INCREASED |
6 |
0.0035 |
| 163 |
STAPHYLOCOCCAL SEPSIS |
17 |
0.0034 |
| 164 |
HAEMOPTYSIS |
96 |
0.0034 |
| 165 |
PERIPHERAL ISCHAEMIA |
14 |
0.0034 |
| 166 |
MOUTH HAEMORRHAGE |
25 |
0.0034 |
| 167 |
EMBOLIC STROKE |
12 |
0.0034 |
| 168 |
MELAENA |
75 |
0.0034 |
| 169 |
VENTRICULAR FIBRILLATION |
37 |
0.0033 |
| 170 |
VENOUS THROMBOSIS |
13 |
0.0033 |
| 171 |
STRESS CARDIOMYOPATHY |
19 |
0.0033 |
| 172 |
AMYLASE INCREASED |
12 |
0.0032 |
| 173 |
SPUTUM INCREASED |
7 |
0.0032 |
| 174 |
ONYCHOMYCOSIS |
14 |
0.0032 |
| 175 |
PARESIS |
7 |
0.0031 |
| 176 |
THROMBOPHLEBITIS |
11 |
0.0031 |
| 177 |
SUBSTANCE-INDUCED PSYCHOTIC DISORDER |
7 |
0.0031 |
| 178 |
RED CELL DISTRIBUTION WIDTH INCREASED |
13 |
0.0031 |
| 179 |
MENINGITIS ASEPTIC |
14 |
0.0031 |
| 180 |
HEPATOSPLENOMEGALY |
8 |
0.0031 |
| 181 |
FOOD ALLERGY |
24 |
0.0031 |
| 182 |
FIBRIN D DIMER INCREASED |
11 |
0.0031 |
| 183 |
VASCULAR DEVICE INFECTION |
14 |
0.0031 |
| 184 |
LARYNGEAL OEDEMA |
19 |
0.0031 |
| 185 |
CEREBRAL INFARCTION |
75 |
0.0031 |
| 186 |
APLASIA |
6 |
0.0031 |
| 187 |
RASH MACULO-PAPULAR |
68 |
0.0031 |
| 188 |
DISSEMINATED INTRAVASCULAR COAGULATION |
43 |
0.0031 |
| 189 |
HAEMORRHAGE |
317 |
0.0030 |
| 190 |
BRAIN OEDEMA |
38 |
0.0030 |
| 191 |
EMPHYSEMA |
30 |
0.0030 |
| 192 |
PULMONARY INFARCTION |
7 |
0.0030 |
| 193 |
ENTEROCOLITIS |
17 |
0.0029 |
| 194 |
NORMAL NEWBORN |
16 |
0.0029 |
| 195 |
CIRCULATORY COLLAPSE |
50 |
0.0029 |
| 196 |
INTRACARDIAC THROMBUS |
9 |
0.0029 |
| 197 |
PNEUMOTHORAX |
46 |
0.0029 |
| 198 |
IRON DEFICIENCY |
13 |
0.0029 |
| 199 |
HYPOPNOEA |
10 |
0.0029 |
| 200 |
URINE ABNORMALITY |
13 |
0.0029 |
| 201 |
NEUROTOXICITY |
50 |
0.0029 |
| 202 |
INFUSION SITE PRURITUS |
9 |
0.0028 |
| 203 |
ELECTROENCEPHALOGRAM ABNORMAL |
9 |
0.0028 |
| 204 |
ACUTE MYOCARDIAL INFARCTION |
84 |
0.0028 |
| 205 |
HYPOPHOSPHATAEMIA |
21 |
0.0028 |
| 206 |
THROMBOTIC THROMBOCYTOPENIC PURPURA |
10 |
0.0028 |
| 207 |
HAEMORRHAGE SUBCUTANEOUS |
10 |
0.0028 |
| 208 |
BLOOD PRESSURE DIASTOLIC INCREASED |
13 |
0.0028 |
| 209 |
GRAND MAL CONVULSION |
26 |
0.0028 |
| 210 |
CATHETER SITE HAEMORRHAGE |
7 |
0.0028 |
| 211 |
VENOOCCLUSIVE DISEASE |
7 |
0.0028 |
| 212 |
GINGIVAL BLEEDING |
38 |
0.0028 |
| 213 |
BACTERAEMIA |
33 |
0.0028 |
| 214 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
14 |
0.0027 |
| 215 |
ANGIOEDEMA |
119 |
0.0027 |
| 216 |
COMPARTMENT SYNDROME |
7 |
0.0027 |
| 217 |
EXTRAVASATION |
11 |
0.0027 |
| 218 |
FACE OEDEMA |
45 |
0.0027 |
| 219 |
COLITIS ISCHAEMIC |
18 |
0.0027 |
| 220 |
URINARY TRACT DISORDER |
12 |
0.0027 |
| 221 |
RADICULOPATHY |
7 |
0.0027 |
| 222 |
HYPERCAPNIA |
8 |
0.0027 |
| 223 |
CENTRAL VENOUS CATHETERISATION |
8 |
0.0026 |
| 224 |
MOUTH SWELLING |
15 |
0.0026 |
| 225 |
HYPERREFLEXIA |
9 |
0.0026 |
| 226 |
CONCUSSION |
20 |
0.0026 |
| 227 |
BRONCHOPULMONARY ASPERGILLOSIS |
20 |
0.0026 |
| 228 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
14 |
0.0026 |
| 229 |
ACUTE MYELOID LEUKAEMIA |
40 |
0.0026 |
| 230 |
BLOOD BLISTER |
8 |
0.0026 |
| 231 |
PHARYNGEAL SWELLING |
25 |
0.0026 |
| 232 |
ESCHERICHIA BACTERAEMIA |
6 |
0.0025 |
| 233 |
SINUS TACHYCARDIA |
36 |
0.0025 |
| 234 |
DIABETES INSIPIDUS |
6 |
0.0025 |
| 235 |
PARTIAL SEIZURES |
13 |
0.0025 |
| 236 |
VENTRICULAR ARRHYTHMIA |
9 |
0.0025 |
| 237 |
NYSTAGMUS |
13 |
0.0024 |
| 238 |
ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS |
19 |
0.0024 |
| 239 |
ANAPHYLACTOID REACTION |
10 |
0.0024 |
| 240 |
PRODUCT LABEL CONFUSION |
14 |
0.0024 |
| 241 |
LOW BIRTH WEIGHT BABY |
19 |
0.0024 |
| 242 |
OSTEITIS |
6 |
0.0024 |
| 243 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
40 |
0.0024 |
| 244 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
12 |
0.0024 |
| 245 |
THROMBOTIC MICROANGIOPATHY |
23 |
0.0024 |
| 246 |
TONGUE OEDEMA |
9 |
0.0024 |
| 247 |
WEIGHT LOSS POOR |
12 |
0.0023 |
| 248 |
BRAIN HERNIATION |
7 |
0.0023 |
| 249 |
HAEMORRHAGE INTRACRANIAL |
35 |
0.0023 |
| 250 |
DEVICE RELATED INFECTION |
36 |
0.0023 |
| 251 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
66 |
0.0023 |
| 252 |
VIRAL UPPER RESPIRATORY TRACT INFECTION |
11 |
0.0023 |
| 253 |
HYPERAESTHESIA |
19 |
0.0023 |
| 254 |
BRONCHOSPASM |
33 |
0.0023 |
| 255 |
HYPOXIA |
81 |
0.0023 |
| 256 |
EPISTAXIS |
171 |
0.0023 |
| 257 |
BLOOD ALBUMIN DECREASED |
18 |
0.0023 |
| 258 |
VULVOVAGINAL DISCOMFORT |
10 |
0.0023 |
| 259 |
OESOPHAGEAL CANDIDIASIS |
9 |
0.0023 |
| 260 |
BLOOD DISORDER |
18 |
0.0022 |
| 261 |
ISCHAEMIC STROKE |
40 |
0.0022 |
| 262 |
CARDIOGENIC SHOCK |
32 |
0.0022 |
| 263 |
HYPERTHERMIA |
17 |
0.0022 |
| 264 |
MATERNAL EXPOSURE DURING BREAST FEEDING |
9 |
0.0022 |
| 265 |
VAGINAL HAEMORRHAGE |
96 |
0.0022 |
| 266 |
HAEMATOMA |
57 |
0.0022 |
| 267 |
POLYURIA |
18 |
0.0022 |
| 268 |
HEPATIC CYTOLYSIS |
28 |
0.0022 |
| 269 |
VENTRICULAR HYPOKINESIA |
7 |
0.0022 |
| 270 |
PROCTALGIA |
14 |
0.0022 |
| 271 |
SHOCK |
50 |
0.0022 |
| 272 |
WOUND HAEMORRHAGE |
8 |
0.0022 |
| 273 |
CYANOSIS |
34 |
0.0022 |
| 274 |
BACTERIAL SEPSIS |
7 |
0.0021 |
| 275 |
HYPERACUSIS |
8 |
0.0021 |
| 276 |
NEUTROPHIL COUNT INCREASED |
22 |
0.0021 |
| 277 |
MYELODYSPLASTIC SYNDROME |
31 |
0.0021 |
| 278 |
RIGHT VENTRICULAR FAILURE |
15 |
0.0021 |
| 279 |
CEREBRAL ISCHAEMIA |
11 |
0.0021 |
| 280 |
PULMONARY EMBOLISM |
199 |
0.0021 |
| 281 |
TACHYCARDIA |
186 |
0.0021 |
| 282 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
21 |
0.0021 |
| 283 |
PLATELET COUNT DECREASED |
222 |
0.0021 |
| 284 |
LUNG CANCER METASTATIC |
6 |
0.0021 |
| 285 |
HYPOALBUMINAEMIA |
16 |
0.0021 |
| 286 |
WOUND SECRETION |
8 |
0.0020 |
| 287 |
ADVERSE REACTION |
27 |
0.0020 |
| 288 |
LIVE BIRTH |
17 |
0.0020 |
| 289 |
DEPRESSION SUICIDAL |
7 |
0.0020 |
| 290 |
ILEUS PARALYTIC |
9 |
0.0020 |
| 291 |
PREMATURE DELIVERY |
32 |
0.0020 |
| 292 |
PROTHROMBIN TIME PROLONGED |
12 |
0.0020 |
| 293 |
AZOTAEMIA |
8 |
0.0020 |
| 294 |
OVARIAN CYST |
20 |
0.0020 |
| 295 |
VENTRICULAR TACHYCARDIA |
33 |
0.0020 |
| 296 |
SUSPECTED OFF LABEL USE |
9 |
0.0020 |
| 297 |
SUPRAVENTRICULAR TACHYCARDIA |
19 |
0.0020 |
| 298 |
OBSTRUCTIVE AIRWAYS DISORDER |
22 |
0.0020 |
| 299 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
9 |
0.0020 |
| 300 |
MYOPATHY |
17 |
0.0020 |
| 301 |
BLOOD BILIRUBIN INCREASED |
53 |
0.0020 |
| 302 |
URINE OUTPUT DECREASED |
17 |
0.0019 |
| 303 |
CONCOMITANT DISEASE AGGRAVATED |
12 |
0.0019 |
| 304 |
TUMOUR LYSIS SYNDROME |
17 |
0.0019 |
| 305 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
34 |
0.0019 |
| 306 |
FOOD INTOLERANCE |
7 |
0.0019 |
| 307 |
INFUSION SITE SWELLING |
12 |
0.0019 |
| 308 |
PARADOXICAL DRUG REACTION |
7 |
0.0019 |
| 309 |
SENSITIVITY TO WEATHER CHANGE |
10 |
0.0019 |
| 310 |
SEIZURE |
219 |
0.0019 |
| 311 |
SKIN EROSION |
6 |
0.0019 |
| 312 |
PROTEIN TOTAL DECREASED |
7 |
0.0019 |
| 313 |
PORTAL VEIN THROMBOSIS |
6 |
0.0019 |
| 314 |
PLEURISY |
11 |
0.0019 |
| 315 |
PAPULE |
13 |
0.0018 |
| 316 |
DERMATITIS CONTACT |
21 |
0.0018 |
| 317 |
STAPHYLOCOCCAL BACTERAEMIA |
8 |
0.0018 |
| 318 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
29 |
0.0018 |
| 319 |
INTESTINAL ISCHAEMIA |
10 |
0.0018 |
| 320 |
BLOOD CREATINE INCREASED |
8 |
0.0018 |
| 321 |
HEPATIC FUNCTION ABNORMAL |
67 |
0.0018 |
| 322 |
CARDIAC ARREST |
148 |
0.0018 |
| 323 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
17 |
0.0018 |
| 324 |
BK VIRUS INFECTION |
6 |
0.0018 |
| 325 |
HAEMATEMESIS |
45 |
0.0018 |
| 326 |
CHOLESTASIS |
34 |
0.0018 |
| 327 |
ELECTROCARDIOGRAM QRS COMPLEX PROLONGED |
9 |
0.0018 |
| 328 |
FEMORAL NECK FRACTURE |
9 |
0.0018 |
| 329 |
ONYCHOCLASIS |
12 |
0.0017 |
| 330 |
HYPOKALAEMIA |
80 |
0.0017 |
| 331 |
PREMATURE BABY |
52 |
0.0017 |
| 332 |
TOXIC EPIDERMAL NECROLYSIS |
26 |
0.0017 |
| 333 |
ACIDOSIS |
13 |
0.0017 |
| 334 |
HYPOTENSION |
340 |
0.0017 |
| 335 |
DIFFUSE LARGE B-CELL LYMPHOMA |
13 |
0.0017 |
| 336 |
EMBOLISM |
14 |
0.0017 |
| 337 |
HAEMOLYSIS |
13 |
0.0017 |
| 338 |
HAEMOLYTIC ANAEMIA |
15 |
0.0017 |
| 339 |
LIP OEDEMA |
7 |
0.0017 |
| 340 |
OESOPHAGITIS |
18 |
0.0016 |
| 341 |
DEEP VEIN THROMBOSIS |
107 |
0.0016 |
| 342 |
THROMBOCYTOPENIA |
184 |
0.0016 |
| 343 |
ATRIOVENTRICULAR BLOCK COMPLETE |
11 |
0.0016 |
| 344 |
LYMPHOCYTE COUNT DECREASED |
29 |
0.0016 |
| 345 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
90 |
0.0016 |
| 346 |
HAEMOGLOBIN DECREASED |
168 |
0.0016 |
| 347 |
PNEUMONIA BACTERIAL |
15 |
0.0016 |
| 348 |
PETECHIAE |
17 |
0.0016 |
| 349 |
STEVENS-JOHNSON SYNDROME |
36 |
0.0016 |
| 350 |
TACHYPNOEA |
22 |
0.0016 |
| 351 |
BLOOD UREA INCREASED |
27 |
0.0016 |
| 352 |
INTERMENSTRUAL BLEEDING |
9 |
0.0016 |
| 353 |
ILEUS |
20 |
0.0016 |
| 354 |
EPSTEIN-BARR VIRUS INFECTION |
10 |
0.0016 |
| 355 |
ALANINE AMINOTRANSFERASE INCREASED |
98 |
0.0016 |
| 356 |
C-REACTIVE PROTEIN INCREASED |
58 |
0.0016 |
| 357 |
PANCYTOPENIA |
89 |
0.0016 |
| 358 |
CEREBRAL HAEMORRHAGE |
57 |
0.0016 |
| 359 |
MUSCLE RIGIDITY |
19 |
0.0016 |
| 360 |
RECTAL HAEMORRHAGE |
68 |
0.0016 |
| 361 |
ESCHERICHIA INFECTION |
13 |
0.0016 |
| 362 |
PLEURAL EFFUSION |
96 |
0.0016 |
| 363 |
ADRENAL INSUFFICIENCY |
19 |
0.0016 |
| 364 |
EOSINOPHIL COUNT INCREASED |
13 |
0.0016 |
| 365 |
CAESAREAN SECTION |
18 |
0.0015 |
| 366 |
FEELING OF BODY TEMPERATURE CHANGE |
9 |
0.0015 |
| 367 |
GASTROINTESTINAL HAEMORRHAGE |
128 |
0.0015 |
| 368 |
OXYGEN SATURATION DECREASED |
86 |
0.0015 |
| 369 |
DRUG ERUPTION |
27 |
0.0015 |
| 370 |
BLOOD IRON DECREASED |
18 |
0.0015 |
| 371 |
NEPHROGENIC ANAEMIA |
7 |
0.0015 |
| 372 |
SWOLLEN TONGUE |
47 |
0.0015 |
| 373 |
DELIRIUM |
52 |
0.0015 |
| 374 |
TOXIC SKIN ERUPTION |
15 |
0.0015 |
| 375 |
ANAL ABSCESS |
8 |
0.0015 |
| 376 |
INFUSION SITE PAIN |
19 |
0.0015 |
| 377 |
HIATUS HERNIA |
19 |
0.0015 |
| 378 |
ENTEROCOCCAL INFECTION |
7 |
0.0014 |
| 379 |
RASH ERYTHEMATOUS |
69 |
0.0014 |
| 380 |
HAEMORRHOIDAL HAEMORRHAGE |
7 |
0.0014 |
| 381 |
SEPSIS |
159 |
0.0014 |
| 382 |
APHASIA |
43 |
0.0014 |
| 383 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
13 |
0.0014 |
| 384 |
INFLAMMATORY MARKER INCREASED |
7 |
0.0014 |
| 385 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
35 |
0.0014 |
| 386 |
ACUTE RESPIRATORY FAILURE |
27 |
0.0014 |
| 387 |
MYDRIASIS |
18 |
0.0014 |
| 388 |
PSEUDOMONAS INFECTION |
12 |
0.0014 |
| 389 |
HYPERPROLACTINAEMIA |
9 |
0.0014 |
| 390 |
HEPATITIS ACUTE |
9 |
0.0014 |
| 391 |
DERMATITIS BULLOUS |
10 |
0.0014 |
| 392 |
MATERNAL EXPOSURE DURING PREGNANCY |
123 |
0.0014 |
| 393 |
THERAPY NON-RESPONDER |
62 |
0.0014 |
| 394 |
VASCULITIS |
16 |
0.0014 |
| 395 |
GENERALISED OEDEMA |
17 |
0.0014 |
| 396 |
WALKING AID USER |
9 |
0.0014 |
| 397 |
INTERSTITIAL LUNG DISEASE |
66 |
0.0014 |
| 398 |
PNEUMONIA ASPIRATION |
34 |
0.0014 |
| 399 |
HEMIPARESIS |
23 |
0.0014 |
| 400 |
WRONG DRUG ADMINISTERED |
12 |
0.0013 |
| 401 |
ODYNOPHAGIA |
8 |
0.0013 |
| 402 |
HYDRONEPHROSIS |
10 |
0.0013 |
| 403 |
SEPTIC SHOCK |
58 |
0.0013 |
| 404 |
POSTOPERATIVE WOUND INFECTION |
9 |
0.0013 |
| 405 |
MULTI-ORGAN FAILURE |
23 |
0.0013 |
| 406 |
MATERNAL EXPOSURE BEFORE PREGNANCY |
9 |
0.0013 |
| 407 |
EPILEPSY |
40 |
0.0013 |
| 408 |
RESPIRATORY DISTRESS |
36 |
0.0013 |
| 409 |
TRANSAMINASES INCREASED |
29 |
0.0013 |
| 410 |
BLOOD PRESSURE DECREASED |
86 |
0.0013 |
| 411 |
GASTRITIS |
34 |
0.0013 |
| 412 |
CHOLANGITIS |
8 |
0.0013 |
| 413 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
51 |
0.0013 |
| 414 |
SUBARACHNOID HAEMORRHAGE |
13 |
0.0013 |
| 415 |
GASTRIC ULCER HAEMORRHAGE |
7 |
0.0013 |
| 416 |
GESTATIONAL DIABETES |
6 |
0.0013 |
| 417 |
ANAEMIA |
240 |
0.0013 |
| 418 |
NECROSIS |
7 |
0.0013 |
| 419 |
AMENORRHOEA |
22 |
0.0013 |
| 420 |
ACUTE PULMONARY OEDEMA |
7 |
0.0012 |
| 421 |
LUNG INFILTRATION |
11 |
0.0012 |
| 422 |
HEPATITIS C |
15 |
0.0012 |
| 423 |
DIZZINESS POSTURAL |
12 |
0.0012 |
| 424 |
RASH PUSTULAR |
9 |
0.0012 |
| 425 |
PERONEAL NERVE PALSY |
7 |
0.0012 |
| 426 |
NEUTROPHIL COUNT DECREASED |
50 |
0.0012 |
| 427 |
MENORRHAGIA |
24 |
0.0012 |
| 428 |
GASTRIC HAEMORRHAGE |
14 |
0.0012 |
| 429 |
ORAL CANDIDIASIS |
16 |
0.0012 |
| 430 |
THROMBOSIS |
96 |
0.0012 |
| 431 |
IRON DEFICIENCY ANAEMIA |
11 |
0.0012 |
| 432 |
EXPOSURE DURING PREGNANCY |
74 |
0.0012 |
| 433 |
KLEBSIELLA INFECTION |
6 |
0.0012 |
| 434 |
TROPONIN INCREASED |
9 |
0.0012 |
| 435 |
BACTERIAL INFECTION |
22 |
0.0012 |
| 436 |
DEFORMITY |
11 |
0.0012 |
| 437 |
FOOT DEFORMITY |
13 |
0.0012 |
| 438 |
HAEMATURIA |
40 |
0.0012 |
| 439 |
CACHEXIA |
6 |
0.0012 |
| 440 |
GASTROENTERITIS |
17 |
0.0012 |
| 441 |
HYPOCALCAEMIA |
22 |
0.0012 |
| 442 |
BENIGN PROSTATIC HYPERPLASIA |
6 |
0.0012 |
| 443 |
HYPERBILIRUBINAEMIA |
12 |
0.0012 |
| 444 |
PRURITUS GENERALISED |
25 |
0.0012 |
| 445 |
TENDERNESS |
12 |
0.0012 |
| 446 |
WHITE BLOOD CELL COUNT INCREASED |
44 |
0.0011 |
| 447 |
PALLOR |
31 |
0.0011 |
| 448 |
SERUM FERRITIN INCREASED |
6 |
0.0011 |
| 449 |
DUODENAL ULCER |
8 |
0.0011 |
| 450 |
PULMONARY TOXICITY |
8 |
0.0011 |
| 451 |
ASPARTATE AMINOTRANSFERASE INCREASED |
60 |
0.0011 |
| 452 |
PHARYNGITIS |
14 |
0.0011 |
| 453 |
RESPIRATORY RATE INCREASED |
10 |
0.0011 |
| 454 |
METABOLIC ACIDOSIS |
36 |
0.0011 |
| 455 |
ACUTE KIDNEY INJURY |
171 |
0.0011 |
| 456 |
LIGAMENT SPRAIN |
11 |
0.0011 |
| 457 |
BRADYCARDIA |
59 |
0.0011 |
| 458 |
HAEMATOCRIT DECREASED |
22 |
0.0011 |
| 459 |
RENAL FAILURE ACUTE |
47 |
0.0011 |
| 460 |
BLOOD URINE PRESENT |
21 |
0.0011 |
| 461 |
DRUG INTERACTION |
175 |
0.0011 |
| 462 |
SALIVARY HYPERSECRETION |
11 |
0.0011 |
| 463 |
UROSEPSIS |
10 |
0.0011 |
| 464 |
NERVE INJURY |
12 |
0.0011 |
| 465 |
PRODUCT DISTRIBUTION ISSUE |
10 |
0.0011 |
| 466 |
PYREXIA |
373 |
0.0011 |
| 467 |
NODULE |
14 |
0.0011 |
| 468 |
MALNUTRITION |
12 |
0.0011 |
| 469 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
8 |
0.0011 |
| 470 |
RESPIRATORY DEPRESSION |
13 |
0.0011 |
| 471 |
NEUROLOGICAL SYMPTOM |
6 |
0.0010 |
| 472 |
TOOTHACHE |
19 |
0.0010 |
| 473 |
PARALYSIS |
15 |
0.0010 |
| 474 |
SUBDURAL HAEMATOMA |
15 |
0.0010 |
| 475 |
ANURIA |
9 |
0.0010 |
| 476 |
JOINT RANGE OF MOTION DECREASED |
14 |
0.0010 |
| 477 |
POST PROCEDURAL COMPLICATION |
20 |
0.0010 |
| 478 |
PHARYNGEAL OEDEMA |
16 |
0.0010 |
| 479 |
FULL BLOOD COUNT ABNORMAL |
11 |
0.0010 |
| 480 |
BLOOD URIC ACID INCREASED |
6 |
0.0010 |
| 481 |
RESPIRATORY FAILURE |
75 |
0.0010 |
| 482 |
HEPATIC FAILURE |
31 |
0.0010 |
| 483 |
ACUTE HEPATIC FAILURE |
14 |
0.0010 |
| 484 |
SPLENOMEGALY |
12 |
0.0010 |
| 485 |
ASCITES |
30 |
0.0010 |
| 486 |
KIDNEY INFECTION |
20 |
0.0010 |
| 487 |
CONTUSION |
98 |
0.0010 |
| 488 |
PRODUCT PRESCRIBING ISSUE |
22 |
0.0010 |
| 489 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
29 |
0.0010 |
| 490 |
HYPOMAGNESAEMIA |
14 |
0.0010 |
| 491 |
PULMONARY OEDEMA |
45 |
0.0010 |
| 492 |
GASTROENTERITIS VIRAL |
18 |
0.0010 |
| 493 |
LEUKOCYTOSIS |
18 |
0.0010 |
| 494 |
BODY TEMPERATURE INCREASED |
20 |
0.0010 |
| 495 |
CYTOPENIA |
12 |
0.0010 |
| 496 |
URTICARIA |
164 |
0.0010 |
| 497 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
10 |
0.0010 |
| 498 |
IMPAIRED QUALITY OF LIFE |
14 |
0.0010 |
| 499 |
GRAFT VERSUS HOST DISEASE |
7 |
0.0010 |
| 500 |
PARAESTHESIA ORAL |
14 |
0.0010 |
| 501 |
EOSINOPHILIA |
17 |
0.0010 |
| 502 |
SPINAL COMPRESSION FRACTURE |
8 |
0.0010 |
| 503 |
THERAPY PARTIAL RESPONDER |
15 |
0.0010 |
| 504 |
DISORIENTATION |
38 |
0.0010 |
| 505 |
CARDIO-RESPIRATORY ARREST |
40 |
0.0010 |
| 506 |
ARTERIOSCLEROSIS |
9 |
0.0010 |
| 507 |
INFUSION SITE ERYTHEMA |
8 |
0.0009 |
| 508 |
SYNCOPE |
94 |
0.0009 |
| 509 |
FACIAL PARALYSIS |
8 |
0.0009 |
| 510 |
ENCEPHALOPATHY |
23 |
0.0009 |
| 511 |
COVID-19 PNEUMONIA |
11 |
0.0009 |
| 512 |
ATELECTASIS |
9 |
0.0009 |
| 513 |
JAUNDICE |
25 |
0.0009 |
| 514 |
ALTERED STATE OF CONSCIOUSNESS |
20 |
0.0009 |
| 515 |
PRODUCT PREPARATION ISSUE |
6 |
0.0009 |
| 516 |
ASPERGILLUS INFECTION |
6 |
0.0009 |
| 517 |
WOUND INFECTION |
10 |
0.0009 |
| 518 |
HYPERKALAEMIA |
32 |
0.0009 |
| 519 |
HYPONATRAEMIA |
51 |
0.0009 |
| 520 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
8 |
0.0009 |
| 521 |
CYTOMEGALOVIRUS INFECTION |
15 |
0.0009 |
| 522 |
FUNGAL INFECTION |
30 |
0.0009 |
| 523 |
URINARY RETENTION |
30 |
0.0009 |
| 524 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
23 |
0.0009 |
| 525 |
TORSADE DE POINTES |
7 |
0.0009 |
| 526 |
SKIN INFECTION |
10 |
0.0009 |
| 527 |
UNRESPONSIVE TO STIMULI |
23 |
0.0009 |
| 528 |
BONE MARROW FAILURE |
18 |
0.0009 |
| 529 |
MOTOR DYSFUNCTION |
9 |
0.0009 |
| 530 |
MYOCARDIAL ISCHAEMIA |
10 |
0.0009 |
| 531 |
PRESCRIBED OVERDOSE |
17 |
0.0009 |
| 532 |
ATRIAL FLUTTER |
7 |
0.0009 |
| 533 |
JOINT STIFFNESS |
23 |
0.0009 |
| 534 |
MIOSIS |
7 |
0.0009 |
| 535 |
PNEUMONIA |
282 |
0.0009 |
| 536 |
DRUG-INDUCED LIVER INJURY |
27 |
0.0009 |
| 537 |
ERYTHEMA MULTIFORME |
8 |
0.0009 |
| 538 |
APPENDICITIS |
8 |
0.0009 |
| 539 |
DISEASE PROGRESSION |
101 |
0.0009 |
| 540 |
FLANK PAIN |
8 |
0.0009 |
| 541 |
CHILLS |
100 |
0.0009 |
| 542 |
HAND FRACTURE |
6 |
0.0008 |
| 543 |
ACUTE CORONARY SYNDROME |
7 |
0.0008 |
| 544 |
PNEUMONITIS |
23 |
0.0008 |
| 545 |
LIP SWELLING |
28 |
0.0008 |
| 546 |
SEROTONIN SYNDROME |
16 |
0.0008 |
| 547 |
DYSMENORRHOEA |
11 |
0.0008 |
| 548 |
SKIN LACERATION |
9 |
0.0008 |
| 549 |
WHEEZING |
49 |
0.0008 |
| 550 |
PRODUCT CONTAINER ISSUE |
7 |
0.0008 |
| 551 |
TOOTH FRACTURE |
9 |
0.0008 |
| 552 |
HAEMATOCHEZIA |
45 |
0.0008 |
| 553 |
HEPATOMEGALY |
8 |
0.0008 |
| 554 |
SWELLING FACE |
53 |
0.0008 |
| 555 |
LIMB INJURY |
22 |
0.0008 |
| 556 |
HYPERCALCAEMIA |
10 |
0.0008 |
| 557 |
PYELONEPHRITIS |
7 |
0.0008 |
| 558 |
RED BLOOD CELL COUNT DECREASED |
23 |
0.0008 |
| 559 |
HYPOTONIA |
8 |
0.0008 |
| 560 |
LEUKOPENIA |
40 |
0.0008 |
| 561 |
RENAL IMPAIRMENT |
67 |
0.0008 |
| 562 |
MIGRAINE |
76 |
0.0008 |
| 563 |
INTENTIONAL SELF-INJURY |
16 |
0.0008 |
| 564 |
HYPOTHERMIA |
8 |
0.0008 |
| 565 |
COORDINATION ABNORMAL |
11 |
0.0008 |
| 566 |
FOETAL EXPOSURE DURING PREGNANCY |
64 |
0.0008 |
| 567 |
PROCEDURAL COMPLICATION |
6 |
0.0008 |
| 568 |
HYPOPHAGIA |
20 |
0.0008 |
| 569 |
OEDEMA PERIPHERAL |
95 |
0.0008 |
| 570 |
GENITAL HAEMORRHAGE |
10 |
0.0008 |
| 571 |
PERITONITIS |
16 |
0.0008 |
| 572 |
APNOEA |
6 |
0.0008 |
| 573 |
HYPOKINESIA |
11 |
0.0008 |
| 574 |
JOINT DISLOCATION |
8 |
0.0008 |
| 575 |
LIVER FUNCTION TEST ABNORMAL |
22 |
0.0008 |
| 576 |
AGRANULOCYTOSIS |
14 |
0.0008 |
| 577 |
WOUND |
21 |
0.0008 |
| 578 |
OFF LABEL USE |
657 |
0.0007 |
| 579 |
HEPATIC ENCEPHALOPATHY |
7 |
0.0007 |
| 580 |
PHOTOPHOBIA |
14 |
0.0007 |
| 581 |
RHINITIS |
6 |
0.0007 |
| 582 |
PRESYNCOPE |
18 |
0.0007 |
| 583 |
DECUBITUS ULCER |
6 |
0.0007 |
| 584 |
PERICARDIAL EFFUSION |
17 |
0.0007 |
| 585 |
PULMONARY THROMBOSIS |
8 |
0.0007 |
| 586 |
NEUTROPENIA |
99 |
0.0007 |
| 587 |
ABDOMINAL PAIN |
169 |
0.0007 |
| 588 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
16 |
0.0007 |
| 589 |
LIVER DISORDER |
32 |
0.0007 |
| 590 |
PULMONARY HYPERTENSION |
15 |
0.0007 |
| 591 |
INTENTIONAL PRODUCT USE ISSUE |
63 |
0.0007 |
| 592 |
ARRHYTHMIA |
34 |
0.0007 |
| 593 |
COLITIS |
27 |
0.0007 |
| 594 |
SENSATION OF FOREIGN BODY |
6 |
0.0007 |
| 595 |
TENDONITIS |
11 |
0.0007 |
| 596 |
HALLUCINATION, VISUAL |
15 |
0.0007 |
| 597 |
CARDIOVASCULAR DISORDER |
18 |
0.0007 |
| 598 |
BLOOD PRESSURE FLUCTUATION |
17 |
0.0007 |
| 599 |
LUNG INFECTION |
11 |
0.0007 |
| 600 |
MITRAL VALVE INCOMPETENCE |
8 |
0.0007 |
| 601 |
HEART RATE INCREASED |
70 |
0.0007 |
| 602 |
BLADDER DISORDER |
7 |
0.0007 |
| 603 |
BLOOD PRESSURE ABNORMAL |
14 |
0.0007 |
| 604 |
HYPERTENSION |
149 |
0.0007 |
| 605 |
RESPIRATORY DISORDER |
21 |
0.0007 |
| 606 |
MEDICATION ERROR |
39 |
0.0007 |
| 607 |
HYPOGLYCAEMIA |
34 |
0.0007 |
| 608 |
CONVULSION |
40 |
0.0007 |
| 609 |
HEAD INJURY |
22 |
0.0007 |
| 610 |
WHITE BLOOD CELL COUNT DECREASED |
75 |
0.0007 |
| 611 |
RESPIRATORY TRACT INFECTION |
18 |
0.0007 |
| 612 |
EYELID OEDEMA |
8 |
0.0007 |
| 613 |
BLOOD PRESSURE INCREASED |
105 |
0.0007 |
| 614 |
OEDEMA |
37 |
0.0007 |
| 615 |
COLD SWEAT |
12 |
0.0007 |
| 616 |
LOSS OF CONSCIOUSNESS |
87 |
0.0007 |
| 617 |
BLISTER |
38 |
0.0007 |
| 618 |
NEUROLEPTIC MALIGNANT SYNDROME |
8 |
0.0007 |
| 619 |
CARDIOTOXICITY |
6 |
0.0007 |
| 620 |
CHOLECYSTITIS |
8 |
0.0007 |
| 621 |
RHABDOMYOLYSIS |
28 |
0.0007 |
| 622 |
HAEMORRHOIDS |
13 |
0.0007 |
| 623 |
DRUG LEVEL INCREASED |
11 |
0.0007 |
| 624 |
HYPOAESTHESIA ORAL |
10 |
0.0007 |
| 625 |
PELVIC PAIN |
12 |
0.0007 |
| 626 |
VOMITING |
310 |
0.0007 |
| 627 |
PRODUCT AVAILABILITY ISSUE |
15 |
0.0007 |
| 628 |
RASH GENERALISED |
17 |
0.0007 |
| 629 |
NO THERAPEUTIC RESPONSE |
8 |
0.0007 |
| 630 |
RESTLESSNESS |
24 |
0.0007 |
| 631 |
AGITATION |
48 |
0.0007 |
| 632 |
RESPIRATORY ARREST |
18 |
0.0007 |
| 633 |
MUSCLE TWITCHING |
15 |
0.0007 |
| 634 |
DIVERTICULITIS |
18 |
0.0006 |
| 635 |
BRONCHITIS |
48 |
0.0006 |
| 636 |
ABNORMAL WEIGHT GAIN |
8 |
0.0006 |
| 637 |
ATRIAL FIBRILLATION |
63 |
0.0006 |
| 638 |
MUSCULOSKELETAL CHEST PAIN |
10 |
0.0006 |
| 639 |
NECK PAIN |
36 |
0.0006 |
| 640 |
BLOOD CREATININE INCREASED |
42 |
0.0006 |
| 641 |
PRODUCT ADMINISTRATION ERROR |
13 |
0.0006 |
| 642 |
TOOTH EXTRACTION |
8 |
0.0006 |
| 643 |
ASPIRATION |
7 |
0.0006 |
| 644 |
BLINDNESS UNILATERAL |
9 |
0.0006 |
| 645 |
RENAL FAILURE |
84 |
0.0006 |
| 646 |
HYPERGLYCAEMIA |
23 |
0.0006 |
| 647 |
CHEST PAIN |
116 |
0.0006 |
| 648 |
INTESTINAL PERFORATION |
7 |
0.0006 |
| 649 |
REBOUND EFFECT |
7 |
0.0006 |
| 650 |
SCAB |
7 |
0.0006 |
| 651 |
BODY TEMPERATURE DECREASED |
6 |
0.0006 |
| 652 |
STAPHYLOCOCCAL INFECTION |
20 |
0.0006 |
| 653 |
HYPERSENSITIVITY |
112 |
0.0006 |
| 654 |
EYE PAIN |
34 |
0.0006 |
| 655 |
NASAL CONGESTION |
35 |
0.0006 |
| 656 |
LYMPHADENOPATHY |
21 |
0.0006 |
| 657 |
CONJUNCTIVITIS |
11 |
0.0006 |
| 658 |
FEEDING DISORDER |
12 |
0.0006 |
| 659 |
DRUG LEVEL DECREASED |
6 |
0.0006 |
| 660 |
PLASMA CELL MYELOMA |
23 |
0.0006 |
| 661 |
INSURANCE ISSUE |
9 |
0.0006 |
| 662 |
PRODUCT PRESCRIBING ERROR |
14 |
0.0006 |
| 663 |
SWELLING |
55 |
0.0006 |
| 664 |
POLYNEUROPATHY |
7 |
0.0006 |
| 665 |
BLOOD SODIUM DECREASED |
11 |
0.0006 |
| 666 |
PERIPHERAL COLDNESS |
8 |
0.0006 |
| 667 |
DYSPHONIA |
34 |
0.0006 |
| 668 |
PARANOIA |
10 |
0.0006 |
| 669 |
EJECTION FRACTION DECREASED |
9 |
0.0006 |
| 670 |
PROTEINURIA |
11 |
0.0006 |
| 671 |
PANCREATITIS ACUTE |
13 |
0.0006 |
| 672 |
MUSCLE SPASMS |
106 |
0.0006 |
| 673 |
PROCEDURAL PAIN |
16 |
0.0006 |
| 674 |
FEELING COLD |
16 |
0.0006 |
| 675 |
HERPES ZOSTER |
33 |
0.0006 |
| 676 |
CARDIAC FAILURE |
46 |
0.0006 |
| 677 |
HEART RATE DECREASED |
20 |
0.0006 |
| 678 |
CLOSTRIDIUM DIFFICILE COLITIS |
6 |
0.0006 |
| 679 |
ABDOMINAL DISTENSION |
59 |
0.0006 |
| 680 |
HEAD DISCOMFORT |
10 |
0.0006 |
| 681 |
INTENTIONAL OVERDOSE |
36 |
0.0006 |
| 682 |
PRODUCT USE IN UNAPPROVED INDICATION |
139 |
0.0006 |
| 683 |
MALIGNANT NEOPLASM PROGRESSION |
57 |
0.0006 |
| 684 |
LACTIC ACIDOSIS |
18 |
0.0006 |
| 685 |
BACK PAIN |
129 |
0.0006 |
| 686 |
BLOOD POTASSIUM INCREASED |
9 |
0.0006 |
| 687 |
FAECES DISCOLOURED |
12 |
0.0006 |
| 688 |
MENTAL DISORDER |
24 |
0.0006 |
| 689 |
PREGNANCY |
11 |
0.0005 |
| 690 |
CHEST DISCOMFORT |
56 |
0.0005 |
| 691 |
PHOTOSENSITIVITY REACTION |
9 |
0.0005 |
| 692 |
CONFUSIONAL STATE |
88 |
0.0005 |
| 693 |
CARDIOMYOPATHY |
8 |
0.0005 |
| 694 |
MENTAL STATUS CHANGES |
15 |
0.0005 |
| 695 |
FEELING HOT |
33 |
0.0005 |
| 696 |
INFLUENZA |
60 |
0.0005 |
| 697 |
GENERAL PHYSICAL HEALTH DETERIORATION |
62 |
0.0005 |
| 698 |
HEPATIC CIRRHOSIS |
10 |
0.0005 |
| 699 |
TREATMENT FAILURE |
44 |
0.0005 |
| 700 |
PULMONARY CONGESTION |
7 |
0.0005 |
| 701 |
DYSPNOEA |
299 |
0.0005 |
| 702 |
INFUSION RELATED REACTION |
35 |
0.0005 |
| 703 |
GASTRIC ULCER |
10 |
0.0005 |
| 704 |
QUALITY OF LIFE DECREASED |
7 |
0.0005 |
| 705 |
FREQUENT BOWEL MOVEMENTS |
14 |
0.0005 |
| 706 |
ELECTROLYTE IMBALANCE |
6 |
0.0005 |
| 707 |
BLINDNESS |
21 |
0.0005 |
| 708 |
LIVER FUNCTION TEST INCREASED |
11 |
0.0005 |
| 709 |
FLATULENCE |
29 |
0.0005 |
| 710 |
PALPITATIONS |
59 |
0.0005 |
| 711 |
DRUG INEFFECTIVE |
662 |
0.0005 |
| 712 |
COVID-19 |
88 |
0.0005 |
| 713 |
APHONIA |
7 |
0.0005 |
| 714 |
ABSCESS |
8 |
0.0005 |
| 715 |
CYTOKINE RELEASE SYNDROME |
10 |
0.0005 |
| 716 |
CONTRAINDICATED PRODUCT ADMINISTERED |
15 |
0.0005 |
| 717 |
TOOTH DISORDER |
11 |
0.0005 |
| 718 |
DIARRHOEA |
319 |
0.0005 |
| 719 |
DYSKINESIA |
20 |
0.0005 |
| 720 |
ORAL PAIN |
11 |
0.0005 |
| 721 |
RASH PAPULAR |
11 |
0.0005 |
| 722 |
LUNG DISORDER |
24 |
0.0005 |
| 723 |
EAR INFECTION |
13 |
0.0005 |
| 724 |
OROPHARYNGEAL PAIN |
45 |
0.0005 |
| 725 |
INFECTION |
70 |
0.0005 |
| 726 |
NEUROPATHY PERIPHERAL |
46 |
0.0005 |
| 727 |
PULMONARY ARTERIAL HYPERTENSION |
7 |
0.0005 |
| 728 |
TUBULOINTERSTITIAL NEPHRITIS |
9 |
0.0005 |
| 729 |
PRODUCT USE ISSUE |
90 |
0.0005 |
| 730 |
POISONING |
6 |
0.0005 |
| 731 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
12 |
0.0005 |
| 732 |
MOUTH ULCERATION |
10 |
0.0005 |
| 733 |
DYSPHAGIA |
45 |
0.0005 |
| 734 |
DRUG EFFECT LESS THAN EXPECTED |
7 |
0.0005 |
| 735 |
METRORRHAGIA |
8 |
0.0005 |
| 736 |
NIGHT SWEATS |
15 |
0.0005 |
| 737 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
6 |
0.0005 |
| 738 |
THERAPEUTIC RESPONSE DECREASED |
28 |
0.0005 |
| 739 |
OSTEOPENIA |
7 |
0.0005 |
| 740 |
NEOPLASM PROGRESSION |
16 |
0.0005 |
| 741 |
CLOSTRIDIUM DIFFICILE INFECTION |
10 |
0.0005 |
| 742 |
HIP ARTHROPLASTY |
7 |
0.0005 |
| 743 |
BEDRIDDEN |
6 |
0.0005 |
| 744 |
INTERNATIONAL NORMALISED RATIO INCREASED |
13 |
0.0005 |
| 745 |
NEURALGIA |
11 |
0.0005 |
| 746 |
DISTURBANCE IN ATTENTION |
24 |
0.0004 |
| 747 |
MYELOSUPPRESSION |
16 |
0.0004 |
| 748 |
BONE PAIN |
26 |
0.0004 |
| 749 |
THROAT TIGHTNESS |
12 |
0.0004 |
| 750 |
NAUSEA |
351 |
0.0004 |
| 751 |
DECREASED APPETITE |
103 |
0.0004 |
| 752 |
EXTRAPYRAMIDAL DISORDER |
11 |
0.0004 |
| 753 |
MYALGIA |
75 |
0.0004 |
| 754 |
WEIGHT DECREASED |
123 |
0.0004 |
| 755 |
MUSCULAR WEAKNESS |
50 |
0.0004 |
| 756 |
TREMOR |
73 |
0.0004 |
| 757 |
URINARY TRACT INFECTION |
75 |
0.0004 |
| 758 |
URINARY INCONTINENCE |
13 |
0.0004 |
| 759 |
ERYTHEMA |
90 |
0.0004 |
| 760 |
SOMNOLENCE |
88 |
0.0004 |
| 761 |
SUICIDAL IDEATION |
40 |
0.0004 |
| 762 |
TINNITUS |
20 |
0.0004 |
| 763 |
COUGH |
122 |
0.0004 |
| 764 |
BLOOD POTASSIUM DECREASED |
13 |
0.0004 |
| 765 |
STOMATITIS |
26 |
0.0004 |
| 766 |
RASH |
186 |
0.0004 |
| 767 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
19 |
0.0004 |
| 768 |
RETCHING |
9 |
0.0004 |
| 769 |
JOINT INJURY |
9 |
0.0004 |
| 770 |
TREATMENT NONCOMPLIANCE |
23 |
0.0004 |
| 771 |
DEHYDRATION |
56 |
0.0004 |
| 772 |
AGGRESSION |
21 |
0.0004 |
| 773 |
LETHARGY |
24 |
0.0004 |
| 774 |
ELECTROCARDIOGRAM QT PROLONGED |
15 |
0.0004 |
| 775 |
DYSPEPSIA |
41 |
0.0004 |
| 776 |
ANOSMIA |
6 |
0.0004 |
| 777 |
HYPOAESTHESIA |
62 |
0.0004 |
| 778 |
LOCALISED INFECTION |
10 |
0.0004 |
| 779 |
INJECTION SITE HAEMATOMA |
6 |
0.0004 |
| 780 |
COMPLICATION ASSOCIATED WITH DEVICE |
6 |
0.0004 |
| 781 |
MENTAL IMPAIRMENT |
10 |
0.0004 |
| 782 |
FLUID OVERLOAD |
6 |
0.0004 |
| 783 |
PANIC ATTACK |
15 |
0.0004 |
| 784 |
CONDITION AGGRAVATED |
125 |
0.0004 |
| 785 |
MALAISE |
180 |
0.0004 |
| 786 |
ARTHRALGIA |
170 |
0.0004 |
| 787 |
DYSURIA |
15 |
0.0004 |
| 788 |
COGNITIVE DISORDER |
19 |
0.0004 |
| 789 |
CONSTIPATION |
88 |
0.0004 |
| 790 |
VISUAL IMPAIRMENT |
50 |
0.0004 |
| 791 |
FLUSHING |
41 |
0.0004 |
| 792 |
OSTEOARTHRITIS |
17 |
0.0004 |
| 793 |
AGEUSIA |
10 |
0.0004 |
| 794 |
RASH MACULAR |
14 |
0.0004 |
| 795 |
PRODUCTIVE COUGH |
19 |
0.0004 |
| 796 |
ILLNESS |
41 |
0.0004 |
| 797 |
INSOMNIA |
106 |
0.0004 |
| 798 |
PERIPHERAL SWELLING |
61 |
0.0004 |
| 799 |
IMPAIRED HEALING |
13 |
0.0004 |
| 800 |
LOWER RESPIRATORY TRACT INFECTION |
18 |
0.0004 |
| 801 |
CEREBROVASCULAR ACCIDENT |
67 |
0.0004 |
| 802 |
THERAPEUTIC RESPONSE SHORTENED |
13 |
0.0004 |
| 803 |
THIRST |
7 |
0.0004 |
| 804 |
NASOPHARYNGITIS |
72 |
0.0004 |
| 805 |
GOUT |
7 |
0.0004 |
| 806 |
UPPER RESPIRATORY TRACT INFECTION |
18 |
0.0004 |
| 807 |
HEADACHE |
244 |
0.0004 |
| 808 |
DIZZINESS |
193 |
0.0004 |
| 809 |
ANGINA PECTORIS |
11 |
0.0004 |
| 810 |
END STAGE RENAL DISEASE |
7 |
0.0004 |
| 811 |
PRODUCT USE COMPLAINT |
6 |
0.0004 |
| 812 |
SINUSITIS |
39 |
0.0004 |
| 813 |
KNEE ARTHROPLASTY |
8 |
0.0004 |
| 814 |
DISEASE RECURRENCE |
18 |
0.0004 |
| 815 |
DISCOMFORT |
23 |
0.0004 |
| 816 |
OBESITY |
6 |
0.0004 |
| 817 |
HEPATIC STEATOSIS |
7 |
0.0004 |
| 818 |
SENSORY DISTURBANCE |
6 |
0.0004 |
| 819 |
MOVEMENT DISORDER |
12 |
0.0004 |
| 820 |
FALL |
124 |
0.0004 |
| 821 |
POOR QUALITY SLEEP |
8 |
0.0004 |
| 822 |
SKIN DISCOLOURATION |
17 |
0.0004 |
| 823 |
ABDOMINAL DISCOMFORT |
62 |
0.0004 |
| 824 |
ANXIETY |
105 |
0.0004 |
| 825 |
PARAESTHESIA |
58 |
0.0004 |
| 826 |
DIABETES MELLITUS |
28 |
0.0004 |
| 827 |
HEPATIC ENZYME INCREASED |
25 |
0.0004 |
| 828 |
CHOLELITHIASIS |
12 |
0.0004 |
| 829 |
SPEECH DISORDER |
19 |
0.0004 |
| 830 |
TOXICITY TO VARIOUS AGENTS |
61 |
0.0004 |
| 831 |
VIRAL INFECTION |
12 |
0.0004 |
| 832 |
POLLAKIURIA |
15 |
0.0004 |
| 833 |
PANCREATITIS |
19 |
0.0004 |
| 834 |
BLOOD PRESSURE SYSTOLIC INCREASED |
7 |
0.0004 |
| 835 |
ORAL HERPES |
7 |
0.0004 |
| 836 |
GASTROINTESTINAL DISORDER |
32 |
0.0004 |
| 837 |
CELLULITIS |
18 |
0.0004 |
| 838 |
HYPERHIDROSIS |
46 |
0.0004 |
| 839 |
TYPE 2 DIABETES MELLITUS |
12 |
0.0004 |
| 840 |
TRANSIENT ISCHAEMIC ATTACK |
12 |
0.0004 |
| 841 |
LIMB DISCOMFORT |
11 |
0.0004 |
| 842 |
CANDIDA INFECTION |
6 |
0.0004 |
| 843 |
FEMUR FRACTURE |
11 |
0.0004 |
| 844 |
DISABILITY |
7 |
0.0004 |
| 845 |
PRODUCT DOSE OMISSION IN ERROR |
10 |
0.0004 |
| 846 |
WEIGHT INCREASED |
79 |
0.0004 |
| 847 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
25 |
0.0004 |
| 848 |
UPPER LIMB FRACTURE |
7 |
0.0004 |
| 849 |
MYOCARDIAL INFARCTION |
61 |
0.0003 |
| 850 |
INFLAMMATION |
18 |
0.0003 |
| 851 |
SUICIDE ATTEMPT |
21 |
0.0003 |
| 852 |
DYSPNOEA EXERTIONAL |
13 |
0.0003 |
| 853 |
MUSCULOSKELETAL PAIN |
18 |
0.0003 |
| 854 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
10 |
0.0003 |
| 855 |
METASTASES TO LIVER |
6 |
0.0003 |
| 856 |
RIB FRACTURE |
7 |
0.0003 |
| 857 |
RENAL INJURY |
10 |
0.0003 |
| 858 |
VISION BLURRED |
46 |
0.0003 |
| 859 |
GAIT DISTURBANCE |
64 |
0.0003 |
| 860 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
60 |
0.0003 |
| 861 |
IRRITABILITY |
20 |
0.0003 |
| 862 |
RASH PRURITIC |
18 |
0.0003 |
| 863 |
EXPIRED PRODUCT ADMINISTERED |
11 |
0.0003 |
| 864 |
ABDOMINAL PAIN UPPER |
68 |
0.0003 |
| 865 |
CRYING |
12 |
0.0003 |
| 866 |
MOOD ALTERED |
9 |
0.0003 |
| 867 |
FIBROMYALGIA |
8 |
0.0003 |
| 868 |
PAIN |
200 |
0.0003 |
| 869 |
PAIN IN EXTREMITY |
95 |
0.0003 |
| 870 |
DEPRESSED MOOD |
17 |
0.0003 |
| 871 |
DYSARTHRIA |
12 |
0.0003 |
| 872 |
HALLUCINATION |
24 |
0.0003 |
| 873 |
HOT FLUSH |
24 |
0.0003 |
| 874 |
ABDOMINAL PAIN LOWER |
8 |
0.0003 |
| 875 |
MUSCULOSKELETAL DISORDER |
6 |
0.0003 |
| 876 |
COMA |
15 |
0.0003 |
| 877 |
ROAD TRAFFIC ACCIDENT |
13 |
0.0003 |
| 878 |
CHROMATURIA |
7 |
0.0003 |
| 879 |
SKIN ULCER |
8 |
0.0003 |
| 880 |
RHINORRHOEA |
20 |
0.0003 |
| 881 |
DYSTONIA |
6 |
0.0003 |
| 882 |
EAR PAIN |
6 |
0.0003 |
| 883 |
DIPLOPIA |
8 |
0.0003 |
| 884 |
DEAFNESS |
8 |
0.0003 |
| 885 |
PRURITUS |
117 |
0.0003 |
| 886 |
ANHEDONIA |
8 |
0.0003 |
| 887 |
ABORTION SPONTANEOUS |
12 |
0.0003 |
| 888 |
JOINT SWELLING |
36 |
0.0003 |
| 889 |
FULL BLOOD COUNT DECREASED |
6 |
0.0003 |
| 890 |
FEAR |
8 |
0.0003 |
| 891 |
FATIGUE |
230 |
0.0003 |
| 892 |
GASTRIC DISORDER |
10 |
0.0003 |
| 893 |
SURGERY |
17 |
0.0003 |
| 894 |
NERVOUS SYSTEM DISORDER |
9 |
0.0003 |
| 895 |
ASTHENIA |
108 |
0.0003 |
| 896 |
NO ADVERSE EVENT |
52 |
0.0003 |
| 897 |
DERMATITIS |
6 |
0.0003 |
| 898 |
LIVER INJURY |
7 |
0.0003 |
| 899 |
HYPOTHYROIDISM |
9 |
0.0003 |
| 900 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
10 |
0.0003 |
| 901 |
CHRONIC KIDNEY DISEASE |
21 |
0.0003 |
| 902 |
OCULAR HYPERAEMIA |
13 |
0.0003 |
| 903 |
ACCIDENTAL OVERDOSE |
10 |
0.0003 |
| 904 |
GASTROOESOPHAGEAL REFLUX DISEASE |
22 |
0.0003 |
| 905 |
BURNING SENSATION |
19 |
0.0003 |
| 906 |
INTESTINAL OBSTRUCTION |
10 |
0.0003 |
| 907 |
MOBILITY DECREASED |
19 |
0.0003 |
| 908 |
NEPHROLITHIASIS |
12 |
0.0003 |
| 909 |
MENSTRUATION IRREGULAR |
7 |
0.0003 |
| 910 |
DRUG INTOLERANCE |
25 |
0.0003 |
| 911 |
OVERDOSE |
55 |
0.0003 |
| 912 |
CYSTITIS |
8 |
0.0003 |
| 913 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
12 |
0.0002 |
| 914 |
AMNESIA |
16 |
0.0002 |
| 915 |
EYE DISORDER |
8 |
0.0002 |
| 916 |
INFLUENZA LIKE ILLNESS |
20 |
0.0002 |
| 917 |
MUSCULOSKELETAL STIFFNESS |
21 |
0.0002 |
| 918 |
GAIT INABILITY |
8 |
0.0002 |
| 919 |
ASTHMA |
27 |
0.0002 |
| 920 |
CARDIAC FAILURE CONGESTIVE |
19 |
0.0002 |
| 921 |
FLUID RETENTION |
12 |
0.0002 |
| 922 |
HEPATITIS |
6 |
0.0002 |
| 923 |
FEELING ABNORMAL |
56 |
0.0002 |
| 924 |
CORONARY ARTERY DISEASE |
7 |
0.0002 |
| 925 |
INJECTION SITE RASH |
7 |
0.0002 |
| 926 |
INJURY |
16 |
0.0002 |
| 927 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
8 |
0.0002 |
| 928 |
BALANCE DISORDER |
19 |
0.0002 |
| 929 |
UNDERDOSE |
16 |
0.0002 |
| 930 |
LUNG NEOPLASM MALIGNANT |
9 |
0.0002 |
| 931 |
ARTHRITIS |
17 |
0.0002 |
| 932 |
OSTEONECROSIS |
7 |
0.0002 |
| 933 |
VISUAL ACUITY REDUCED |
7 |
0.0002 |
| 934 |
THERAPY INTERRUPTED |
15 |
0.0002 |
| 935 |
NEOPLASM MALIGNANT |
14 |
0.0002 |
| 936 |
DEPRESSION |
47 |
0.0002 |
| 937 |
LABORATORY TEST ABNORMAL |
6 |
0.0002 |
| 938 |
EMOTIONAL DISORDER |
6 |
0.0002 |
| 939 |
ACCIDENTAL EXPOSURE TO PRODUCT |
20 |
0.0002 |
| 940 |
MEMORY IMPAIRMENT |
26 |
0.0002 |
| 941 |
DEATH |
161 |
0.0002 |
| 942 |
UNEVALUABLE EVENT |
14 |
0.0002 |
| 943 |
RHEUMATOID ARTHRITIS |
21 |
0.0002 |
| 944 |
CATARACT |
11 |
0.0002 |
| 945 |
BREAST CANCER |
17 |
0.0002 |
| 946 |
COLITIS ULCERATIVE |
8 |
0.0002 |
| 947 |
THERAPY CESSATION |
9 |
0.0002 |
| 948 |
DRY MOUTH |
14 |
0.0002 |
| 949 |
RENAL DISORDER |
8 |
0.0002 |
| 950 |
ACNE |
13 |
0.0002 |
| 951 |
OSTEOPOROSIS |
7 |
0.0002 |
| 952 |
DEVICE EXPULSION |
11 |
0.0002 |
| 953 |
WITHDRAWAL SYNDROME |
7 |
0.0002 |
| 954 |
INCORRECT DOSE ADMINISTERED |
38 |
0.0002 |
| 955 |
ALOPECIA |
32 |
0.0002 |
| 956 |
PRODUCT DOSE OMISSION ISSUE |
46 |
0.0002 |
| 957 |
ILL-DEFINED DISORDER |
9 |
0.0001 |
| 958 |
DRUG WITHDRAWAL SYNDROME |
13 |
0.0001 |
| 959 |
PSORIATIC ARTHROPATHY |
6 |
0.0001 |
| 960 |
ARTHROPATHY |
8 |
0.0001 |
| 961 |
SKIN EXFOLIATION |
12 |
0.0001 |
| 962 |
SLEEP DISORDER |
10 |
0.0001 |
| 963 |
ADVERSE EVENT |
13 |
0.0001 |
| 964 |
EMOTIONAL DISTRESS |
17 |
0.0001 |
| 965 |
HYPOACUSIS |
6 |
0.0001 |
| 966 |
VERTIGO |
8 |
0.0001 |
| 967 |
INJECTION SITE REACTION |
9 |
0.0001 |
| 968 |
DRUG EFFECT DECREASED |
7 |
0.0001 |
| 969 |
BLOOD CHOLESTEROL INCREASED |
6 |
0.0001 |
| 970 |
BLOOD GLUCOSE INCREASED |
24 |
0.0001 |
| 971 |
INTENTIONAL PRODUCT MISUSE |
11 |
0.0001 |
| 972 |
DYSGEUSIA |
9 |
0.0001 |
| 973 |
DRY SKIN |
16 |
0.0001 |
| 974 |
INJECTION SITE SWELLING |
9 |
0.0001 |
| 975 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
6 |
0.0001 |
| 976 |
NERVOUSNESS |
6 |
0.0001 |
| 977 |
INJECTION SITE PAIN |
35 |
0.0001 |
| 978 |
DERMATITIS ATOPIC |
6 |
0.0001 |
| 979 |
INJECTION SITE ERYTHEMA |
13 |
0.0001 |
| 980 |
DEVICE ISSUE |
9 |
0.0001 |
| 981 |
INJECTION SITE HAEMORRHAGE |
8 |
0.0001 |
| 982 |
HOSPITALISATION |
15 |
0.0001 |
| 983 |
DRUG ABUSE |
8 |
0.0001 |
| 984 |
INJECTION SITE PRURITUS |
6 |
0.0001 |
| 985 |
PRODUCT QUALITY ISSUE |
12 |
0.0001 |
| 986 |
CARDIAC DISORDER |
8 |
0.0001 |
| 987 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
6 |
0.0001 |
| 988 |
ADVERSE DRUG REACTION |
7 |
0.0001 |
| 989 |
INJECTION SITE BRUISING |
6 |
0.0001 |
| 990 |
PSORIASIS |
9 |
0.0001 |
| 991 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
13 |
0.0001 |
| 992 |
DRUG DEPENDENCE |
6 |
0.0000 |